Paragon 28 Inc (FRA:7GQ)
€ 9.75 0.4 (4.28%) Market Cap: 819.46 Mil Enterprise Value: 887.25 Mil PE Ratio: 0 PB Ratio: 6.19 GF Score: 34/100

Paragon 28 Inc at Bank of America Global Healthcare Conference Transcript

May 10, 2023 / 09:20PM GMT
Release Date Price: €15.4 (-3.14%)
Craig William Bijou
BofA Securities, Research Division - Research Analyst

Good afternoon. My name is Craig Bijou. I'm one of the medical device analysts here at BofA. And it's a pleasure to welcome Paragon 28. And from the company, Albert De Costa, the CEO; and Steve Deitsch, CFO. So thank you.

Questions & Answers

Craig William Bijou;Albert DaCosta
BofA Securities, Research Division - Research Analyst;Paragon 28, Inc. - Co-Founder, Chairman, President & CEO

I want to start, you reported Q1 results last week. So I just kind of want to start it with maybe a little bit of a recap. Obviously, growth was pretty strong, 27% constant currency basis on what was a pretty tough comp in the prior year. So if you could just go into a little bit of what drove the strength in the quarter? I know you had mentioned 20% plus growth in the U.S. across all of your foot and ankle segments. But maybe I'll push you a little bit on that too and see if there's anything that stood out in the quarter, but would love to hear your view.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot